Ongoing research into the drug are uncovering significant potential beyond its initial use for type 2 diabetes. Researchers are actively investigating how this GLP-1 analog affects metabolic health, the heart, and potentially brain health. The data indicate a wide spectrum of future treatments, driving additional exploration and research projects.